ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Surgeons, Intramural Scientists Concerned About Representation

November 26, 1976

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

In Brief: Ovarian Cancer Coalition Opens Office; Winchester Leads Surgical Oncologists

July 11, 1997

Cancer Congress Program Developed

June 27, 1980

NCI-Approved CTEP Trials For the Month of October

October 26, 2012

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989